DSIP (delta-sleep inducing peptide) regulates melatonin production and reduces cortisol levels. It improves sleep depth and structure, restores adaptive reserves in chronic stress. Used for insomnia, anxiety, and sleep disorders without dependency.
Raw MaterialUSA
Country of OriginUAE
Purity99%
Raw MaterialUSA
Purity99%
Country of OriginUAE
Indications
Insomnia
Emotional exhaustion
Circadian rhythm disorders
Support in anti-stress protocols
Sleep biohacking
Contraindications
Acute mental disorders
Pregnancy and lactation
Hormonal sleep disturbances (uncontrolled)
Idiosyncrasy.
DSIP (Delta Sleep-Inducing Peptide) is a neuroendocrine-regulating peptide that restores healthy sleep architecture, enhances slow-wave sleep, and reduces hyperarousal within stress-response circuits. The molecule modulates the hy...
DSIP (Delta Sleep-Inducing Peptide) is a neuroendocrine-regulating peptide that restores healthy sleep architecture, enhances slow-wave sleep, and reduces hyperarousal within stress-response circuits. The molecule modulates the hypothalamic–pituitary–adrenal axis, helps normalize cortisol secretion, enhances GABAergic signaling, and stabilizes neuronal rhythms essential for deep restorative sleep.
With its high bioavailability, peptide provides a rapid neurotrophic effect, improving sleep onset and increasing slow-wave phases. Clinical observations indicate that DSIP may reduce nighttime awakenings by 35–40% and stabilize circadian fluctuations in individuals experiencing sleep disturbances, exhaustion, or chronic stress.
DSIP is suitable for individuals who require fast and pronounced sleep regulation — including those with chronic fatigue, moderate anxiety, disrupted circadian rhythms, or recovery after emotional and cognitive overload. The format is used in anti-stress protocols, sleep-quality recovery programs, neuroendocrine support strategies, and comprehensive resilience-enhancement systems.